Inactive Instrument
InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
INCR
IL0011063760
Healthcare Facilities & Services
| Market Cap | 194M 595M 171M 162M 147M 276M 18.64B 278M 1.94B 748M 9.52B 729M 714M 30.58B | P/E 2024 |
-4.01x | P/E 2025 | -4.87x |
|---|---|---|---|---|---|
| Enterprise Value | 331M 1.01B 292M 276M 250M 469M 31.73B 473M 3.3B 1.27B 16.2B 1.24B 1.21B 52.04B | EV / Sales 2024 |
1.69x | EV / Sales 2025 | 1.16x |
| Free-Float |
60.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.22% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 29/02/2020 |
Itai Kabiljo
LAW | General Counsel | - | 31/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 02/09/2015 | |
David Salton
BRD | Director/Board Member | 66 | 13/12/2014 |
| Chairman | 55 | 12/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.22% | -0.51% | - | - | 61.95M | |
| -1.27% | +7.64% | +17.42% | +272.73% | 384M | |
| -1.96% | -3.85% | -36.44% | -15.25% | 152M | |
| +1.85% | +8.37% | +28.65% | +129.17% | 151M | |
| +6.78% | +26.00% | +1.61% | -35.71% | 120M | |
| +1.93% | +0.68% | -34.36% | -45.71% | 61.95M | |
| Average | +1.26% | +2.79% | -4.62% | +61.04% | 173.75M | |
| Weighted average by Cap. | +0.47% | +2.62% | +4.05% | +132.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 239M 731M 211M 199M 181M 339M 22.92B 342M 2.39B 919M 11.71B 897M 877M 37.6B | 270M 828M 238M 225M 204M 383M 25.93B 387M 2.7B 1.04B 13.24B 1.01B 992M 42.53B |
| Net income | -67.8M -208M -59.79M -56.56M -51.25M -96.19M -6.51B -97.04M -677M -261M -3.32B -255M -249M -10.67B | -35.71M -109M -31.49M -29.79M -27M -50.67M -3.43B -51.11M -357M -137M -1.75B -134M -131M -5.62B |
| Net Debt | 133M 407M 117M 111M 100M 188M 12.74B 190M 1.33B 511M 6.51B 498M 488M 20.9B | 136M 418M 120M 114M 103M 193M 13.08B 195M 1.36B 525M 6.68B 512M 501M 21.46B |
Employees
-
